Arvinas, Inc. (ARVN)
13.48
+0.52
(+4.01%)
USD |
NASDAQ |
Feb 06, 16:00
13.48
0.00 (0.00%)
After-Hours: 20:00
Arvinas SG&A Expense (TTM) : 107.00M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Genprex, Inc. | 6.261M |
| Olema Pharmaceuticals, Inc. | 18.61M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |